Steven Cohen's ROIV Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 4.47 M shares of Roivant Sciences Ltd. (ROIV) worth $158.32 M, representing 0.17% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ROIV, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 3.58 M shares. Largest reduction occurred in Q4 2025, reducing 2.61 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +3.58 M | Add 402.13% | 4.47 M | $35.39 |
| Q1 2026 | +890,900 | New Buy | 890,900 | $27.70 |
| Q4 2025 | -2.61 M | Sold Out | 0 | $0.00 |
| Q3 2025 | -342,838 | Reduce 11.62% | 2.61 M | $15.13 |
| Q2 2025 | +2.34 M | Add 380.39% | 2.95 M | $11.27 |
| Q1 2025 | +614,315 | New Buy | 614,315 | $10.09 |
| Q3 2024 | -647,126 | Sold Out | 0 | $0.00 |
| Q2 2024 | +185,226 | Add 40.10% | 647,126 | $10.57 |
| Q1 2024 | +28,200 | Add 6.50% | 461,900 | $10.54 |
| Q4 2023 | -2.27 M | Reduce 83.98% | 433,700 | $11.23 |
| Q3 2023 | +2.71 M | New Buy | 2.71 M | $11.68 |
| Q1 2023 | -576,800 | Sold Out | 0 | $0.00 |
| Q4 2022 | +576,800 | New Buy | 576,800 | $7.99 |
| Q3 2022 | -876,996 | Sold Out | 0 | $0.00 |
| Q2 2022 | +876,996 | New Buy | 876,996 | $4.07 |
Steven Cohen's Roivant Sciences Investment FAQs
Steven Cohen first purchased Roivant Sciences Ltd. (ROIV) in Q2 2022, acquiring 876,996 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Roivant Sciences Ltd. (ROIV) for 15 quarters since Q2 2022.
Steven Cohen's largest addition to Roivant Sciences Ltd. (ROIV) was in Q2 2026, adding 4,473,478 shares worth $158.32 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 4,473,478 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $158.32 M.
As of the Q2 2026 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.17% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Roivant Sciences Ltd. (ROIV) was 4,473,478 shares, as reported at the end of Q2 2026.